Product Program year 2024 Source: CMS Open Payments

Rotarix

Biological Vaccines

NDC 58160-854-52

Open in the dashboard

General payments

$187,835

9,149 payments

Research payments

$0

0 payments

Through program year 2024, $187,835 in general payments and $0 in research payments were reported against Rotarix (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2024 General $71,322 3,851
2023 General $81,655 4,302
2022 General $4,112 198
2021 General $7,428 312
2020 General $19,434 269
2019 General $3,884 217

Breakdown

Who paid General payments · program years 2019–2024
  1. GlaxoSmithKline, LLC. $187,835 9,149 payments
Top recipients General payments · program year 2024
  1. Douglas Gonzales Pediatrics · Lafayette, LA $113 <1% · 7 payments
  2. Melissa Hebert Pediatrics · Lafayette, LA $112 <1% · 6 payments
  3. Stuart Clark Pediatrics · Shreveport, LA $112 <1% · 6 payments
  4. Abigail Felix Nurse Practitioner, Pediatrics · Bronx, NY $109 <1% · 4 payments
  5. Marlene Flores Nurse Practitioner · Houston, TX $108 <1% · 6 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pediatrics $35,924 52% · 1,462 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $8,028 12% · 364 practitioners
  3. Nurse Practitioner, Pediatrics Nurse Practitioner $6,629 10% · 289 practitioners
  4. Family Medicine $4,762 7% · 244 practitioners
  5. Physician Assistant $3,716 5% · 166 practitioners

The top 5 of 79 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Florida $8,377 12% · 331 recipients
  2. California $6,733 9% · 261 recipients
  3. Texas $6,437 9% · 255 recipients
  4. New Jersey $4,915 7% · 209 recipients
  5. New York $4,704 7% · 165 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

9,149 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record